Trump’s Pick to Head FDA Is In Bed With Big Pharma

Listen to story:
Play

FEATURING MICHAEL CAROME – While much of the media focuses on Donald Trump’s 12-year old tax returns that revealed mostly that he is wealthy and paid an expected tax rate of 25%, Trump’s dismantling of federal agencies continues unabated.

To head the US Food and Drug Administration (FDA), Trump has picked Scott Gottlieb, a man with very deep connections to the very industry he’s supposed to regulate: Pharmaceuticals.

Gottlieb has served on the boards of various pharmaceutical companies and has received payments from such behemoths as GlaxoSmithKline and Pfizer. He is a venture capitalist with New Enterprise Associates and is affiliated with the ultra-conservative, pro-corporate think tank, the American Enterprise Institute which believes that regulations that protect public health stifle the economy.

For more information visit www.citizen.org.

Michael Carome, Director of Public Citizen’s Health Research Group.